Insights from BCC Research

This Pill Swallowing You? (Part Two)

Posted by Chris Spivey on Jun 11, 2018 8:46:00 AM

Pharmaceutical Drug

It is now normal to call biotech and small pharma the innovation engines for the pharmaceutical industry. IPO and ICOs abound, as dollars from venture capital truly flood the ecosystem. In 2018, biopharma investment is having a moment. Any big fluctuation, even a positive one, makes stakeholders nervous. Some of the investors might be tourists—Amazon, Google, Apple, IBM, JP Morgan, Berkshire Hathaway and a half dozen others are new entrants, whose long term goals remain unclear. Particularly disturbing are the health insurance and supply chain changes that make headlines, such as this one.

Read More

Topics: Life Sciences, Pharmaceuticals

This Pill Swallowing You?

Posted by Chris Spivey on Jun 4, 2018 12:04:00 PM

Pill

Urgency for an Antidote to Elephantitis

Read More

Topics: Life Sciences, Pharmaceuticals

Among Other Apps, Smart Pills Could Help Staunch the Opioid Epidemic

Posted by Laurie L. Sullivan on Feb 7, 2018 11:30:00 AM

Pill_Bottle.jpgThe opioid epidemic continues as one of America’s greatest public health crises as healthcare officials, public officials and countless Americans struggle to prevent opioid abuse, addiction and death. In a blog from 2017, Laurie Sullivan explores how one solution, known as The Smart Pill Drug Delivery Device, could be used to curb the crisis. Another possible solution? Prescribing more non-opioid painkillers. Click here to be notified when the BCC Research report “Non-opioid Pain Treatment: Global Markets to 2022” publishes later this month.

Smart pills are increasingly influencing our health. They are noninvasive and have redefined diagnosis, disease monitoring, and treatment adherence. By 2021, US sales of smart pills may double, reaching $1.2 billion. The global market for smart pills is poised to exceed a 20% compound annual growth rate (CAGR) during the next five years, according to BCC Research’s recent study, Smart Pills: Applications and Global Markets. High-growth application areas include capsule endoscopy, patient monitoring, and delivery of therapeutic agents. The adoption of advanced ingestible medical sensor technologies is a key growth driver.

Read More

Topics: Life Sciences, Pharmaceuticals

FDA Approves First Digital Pill in Growing Medication Adherence Market

Posted by Laurie L. Sullivan on Dec 11, 2017 11:00:00 AM

First Digital Pill.jpegA higher incidence of chronic diseases worldwide and the demand for advanced medication adherence systems are fueling growth in this market, which has the potential to surpass $3.9 billion by 2021. A new study by BCC Research examines the industry’s prospects and technologies by disease applications and geographical regions.

Read More

Topics: Life Sciences, Pharmaceuticals